鈥楳agic bullet鈥 drugs offer new hope against cancer
Print Edition
Chinese experts on malignant tumors on Saturday released the country鈥檚 first expert consensus on the clinical application of antibody-drug conjugates, providing references on the use of the innovative anticancer drugs.
Known as 鈥渕agic bullets,鈥 antibody-drug conjugates use antibodies as a carrier and a molecular GPS to efficiently transport small molecular cytotoxic drugs to target tumor cells. The antibody connects cytotoxic drugs by a linker molecule. The ADCs have emerged as one of the most promising classes of anti-cancer drugs in recent years.
Expert consensus refers to an agreed-upon set of principles to address the key questions facing clinicians in a specific field, providing practical guidance in an area where evidence may be limited, new and evolving.
The Chinese Anti-Cancer Association, the National Cancer Quality Control Center and other institutions drew together malignant tumor experts from across the country to formulate the expert consensus. It was introduced at a two-day annual meeting of the CACA and will be published in the Chinese Journal of Oncology next January.
The expert consensus gives a systematic review of the eight currently available ADC drugs. So far, there are two ADC drugs approved to enter the Chinese market and six others that have been approved by the US Food and Drug Administration.
The consensus will help clinicians to develop an in-depth understanding of the molecular characteristics and mechanism of ADC drugs, rationally choose the appropriate dose and course of treatment, and manage adverse events.
Ma Fei, a professor from the National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, drafted the consensus. He said the mechanism of ADC drugs has the potential to become the development direction of medical treatment in the future, especially in cancer treatment.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
